Infectious Disease · PANCE / PANRE

Toxoplasmosis

Obligate intracellular protozoan infection (Toxoplasma gondii) — usually asymptomatic, but causes severe congenital disease and CNS lesions in immunocompromised hosts.

Also known as: toxoplasmosis, Toxoplasma gondii, congenital toxoplasmosis, CNS toxoplasmosis

Overview

Infection by Toxoplasma gondii, an obligate intracellular protozoan with cats as the definitive host. Humans are intermediate hosts, acquiring infection via ingestion of oocysts (cat feces, contaminated water/soil) or tissue cysts (undercooked meat). Lifelong latent infection persists in tissue cysts.

Epidemiology

Seroprevalence ~10-20% in US adults, higher in older adults and immigrants; up to 60-80% in parts of Europe and South America. Estimated 750,000-1.1 million new US infections yearly. Second leading cause of foodborne deaths in the US.

Try two board-style Toxoplasmosis questions

Real questions from the FirstPassPA bank, with the full explanation. Pick an answer — no signup, no email.

Question 1Infectious DiseaseMedium
A 41-year-old man with untreated HIV infection (CD4 count 42 cells/µL) presents with 10 days of worsening headache, low-grade fever, and new right-arm weakness. Toxoplasma IgG is positive and IgM is negative. MRI of the brain shows multiple ring-enhancing lesions with surrounding edema in the basal ganglia and at the gray-white junction. He is diagnosed with CNS toxoplasmosis. Which of the following best explains the findings?
  • AImmune complex deposition in cerebral vessels triggering a focal necrotizing vasculitis
  • BNewly acquired primary infection seeding the brain hematogenously after gut invasion
  • CDirect viral cytopathic injury to oligodendrocytes causing white-matter demyelination
  • DReactivation of latent tissue cysts as bradyzoites convert to dividing tachyzoites
Reveal answer & full explanation
Correct answer: D — Reactivation of latent tissue cysts as bradyzoites convert to dividing tachyzoites
  • AImmune complex deposition in cerebral vessels triggering a focal necrotizing vasculitis
  • BNewly acquired primary infection seeding the brain hematogenously after gut invasion
  • CDirect viral cytopathic injury to oligodendrocytes causing white-matter demyelination
  • DReactivation of latent tissue cysts as bradyzoites convert to dividing tachyzoites

Why Reactivation of latent tissue cysts as bradyzoites convert to dividing tachyzoites is correct

  • After primary Toxoplasma infection, cell-mediated immunity (CD4 T cells, IFN-gamma) contains the organism but never eliminates it; latent tissue cysts containing bradyzoites persist for life in brain, muscle, eye, and heart.
  • When CD4 counts fall below 100 cells/µL in HIV (here 42), this surveillance fails and bradyzoites reactivate into rapidly dividing tachyzoites, producing necrotizing encephalitis seen as multiple ring-enhancing lesions in the basal ganglia and gray-white junction.
  • A positive IgG with negative IgM reflects remote, latent infection that has reactivated, the expected serologic pattern; a negative IgG essentially excludes CNS toxoplasmosis in HIV.

Why the others are wrong

  • Newly acquired primary infection seeding the brain hematogenously after gut invasion describes the initial-infection cascade; CNS disease in AIDS is reactivation of old cysts, not fresh ingestion, and the negative IgM argues against acute primary infection.
  • Immune complex deposition in cerebral vessels triggering a focal necrotizing vasculitis is a humoral, type III mechanism; toxoplasmosis is a cell-mediated, intracellular process and the lesions are abscess-like necrosis, not vasculitic infarcts.
  • Direct viral cytopathic injury to oligodendrocytes causing white-matter demyelination is the mechanism of PML (JC virus), which causes non-enhancing white-matter lesions without mass effect; Toxoplasma is a protozoan and these lesions enhance with edema and mass effect.
Question 2Infectious DiseaseMedium
A 38-year-old man with untreated HIV (CD4 count 42 cells/µL) presents with a 10-day history of worsening headache, low-grade fever, and new right-arm weakness. On exam he is afebrile, somnolent but arousable, with right-sided hemiparesis. MRI of the brain with contrast shows multiple ring-enhancing lesions with surrounding edema in the basal ganglia and at the gray-white junction. Serum Toxoplasma IgG is positive. Which of the following is the most appropriate initial management?
  • AVancomycin, ceftriaxone, and IV ampicillin
  • BLiposomal amphotericin B and oral flucytosine
  • CPyrimethamine, sulfadiazine, and leucovorin
  • DIsoniazid, rifampin, pyrazinamide, ethambutol
Reveal answer & full explanation
Correct answer: C — Pyrimethamine, sulfadiazine, and leucovorin
  • AVancomycin, ceftriaxone, and IV ampicillin
  • BLiposomal amphotericin B and oral flucytosine
  • CPyrimethamine, sulfadiazine, and leucovorin
  • DIsoniazid, rifampin, pyrazinamide, ethambutol

Why Pyrimethamine, sulfadiazine, and leucovorin is correct

  • The clinical picture — advanced HIV with CD4 below 100, subacute focal neurologic deficits, multiple ring-enhancing lesions favoring the basal ganglia/gray-white junction, and positive Toxoplasma IgG — is CNS toxoplasmosis until proven otherwise.
  • IDSA/NIH OI guidelines name pyrimethamine + sulfadiazine + leucovorin as preferred first-line induction therapy (6 weeks), with leucovorin to prevent pyrimethamine-induced myelosuppression; clinical and radiographic improvement within ~2 weeks supports the empiric diagnosis. TMP-SMX is an accepted alternative.

Why the others are wrong

  • Liposomal amphotericin B and oral flucytosine treat cryptococcal CNS disease; cryptococcomas are typically smaller and accompanied by a positive cryptococcal antigen, not the multifocal basal-ganglia ring lesions seen here.
  • Isoniazid, rifampin, pyrazinamide, ethambutol treat CNS tuberculosis/tuberculoma, which classically shows an indolent course with basal meningeal enhancement, not multiple gray-white-junction ring lesions in this CD4 range.
  • Vancomycin, ceftriaxone, and IV ampicillin provide empiric coverage for acute bacterial meningitis (including Listeria in an immunocompromised host), which presents more acutely with meningismus and does not match this subacute, multifocal, IgG-positive presentation.
🔒 Free preview limit reached

Keep reading — start your free trial

You've read your 2 free diagnosis previews. Create your free account to unlock the full Toxoplasmosis outline — plus all 514 diagnoses, 6,500+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.

Free to start · No credit card · Cancel anytime

Risk factors

  • Ingestion of undercooked or raw meat (especially pork, lamb, venison)
  • Cat litter exposure (especially outdoor cats); soil/garden contact without gloves
  • Unfiltered/untreated water in endemic areas
  • Pregnancy (highest risk if primary infection in second/third trimester)
  • Immunocompromise: HIV with CD4 <100, hematopoietic transplant, lymphoma

Pathophysiology

Ingested oocysts/cysts release sporozoites/bradyzoites that invade gut epithelium, transform into tachyzoites, and disseminate hematogenously. Cell-mediated immunity controls infection but does not eliminate tissue cysts (containing bradyzoites) in brain, muscle, eye, and heart. Reactivation occurs when CD4 cells decline (HIV) or with immunosuppression. Congenital transmission risk rises from ~10% in first trimester to ~80% in third trimester, but severity is inverse (severe disease more common with early transmission).

Clinical presentation

Symptoms

  • Immunocompetent: usually asymptomatic; minority develop bilateral non-tender cervical lymphadenopathy, fatigue, low-grade fever, myalgia (mononucleosis-like)
  • Ocular toxoplasmosis: blurred vision, floaters, eye pain, scotomata — usually reactivation
  • Congenital toxoplasmosis: classic triad of chorioretinitis, hydrocephalus, and diffuse intracranial calcifications; may also have seizures, hepatosplenomegaly, jaundice, microcephaly, IUGR; many asymptomatic at birth but develop chorioretinitis or learning disabilities later
  • AIDS-associated CNS toxoplasmosis (CD4 <100): subacute headache, focal neuro deficits, seizures, altered mental status, fever

Signs / physical exam

  • Non-tender posterior cervical lymphadenopathy (acute acquired)
  • Chorioretinitis on funduscopy: yellow-white focal retinal lesion with overlying vitreous inflammation
  • Focal CNS deficits, hemiparesis, papilledema
  • Congenital: hepatosplenomegaly, jaundice, blueberry-muffin rash, microcephaly or macrocephaly

Classic findings

AIDS patient with CD4 <100, headache, focal neuro deficit, and multiple ring-enhancing brain lesions on MRI in the basal ganglia or gray-white junction — toxoplasmosis until proven otherwise. Congenital infection: diffuse intracranial calcifications (vs. periventricular in CMV).

Differential diagnosis

  • CNS lymphoma (HIV) — Single lesion (toxoplasmosis usually multiple), no response to empiric anti-toxo therapy, positive EBV PCR in CSF; thallium SPECT positive (negative in toxo)
  • Tuberculous meningitis/tuberculoma — Indolent course, basal meningeal enhancement, IGRA/CSF PCR
  • Progressive multifocal leukoencephalopathy (PML) — JC virus, non-enhancing white matter lesions, no mass effect; CSF PCR positive
  • Cryptococcoma — Cryptococcal antigen positive; smaller lesions
  • EBV mononucleosis — Pharyngitis prominent, heterophile positive
  • CMV/other TORCH (congenital) — Overlapping features; targeted serology and PCR
  • Glioma or metastasis — Less typical for HIV-stage 3; biopsy if no response to empiric therapy

Diagnostic workup

Diagnostic criteria

Clinical syndrome + serology/PCR + imaging. CNS toxoplasmosis in HIV often diagnosed empirically with response to therapy (2-week trial); biopsy if no improvement.

Labs

  • Toxoplasma IgG (lifelong) and IgM (acute; IgM can persist >1 year)
  • IgG avidity (high avidity excludes recent infection — useful in pregnancy)
  • PCR — amniotic fluid (congenital diagnosis), CSF (CNS toxo), aqueous humor (ocular), blood (transplant recipients)
  • Lymph node biopsy — characteristic Piringer-Kuchinka pattern in acquired adenopathy
  • Negative IgG essentially excludes CNS toxoplasmosis in HIV

Imaging

  • MRI brain with contrast: multiple ring-enhancing lesions with surrounding edema, predilection for basal ganglia and gray-white junction
  • CT (if MRI unavailable): hypodense lesions with ring enhancement
  • Fetal ultrasound: hydrocephalus, intracranial calcifications, IUGR, hepatosplenomegaly
  • Funduscopic exam for chorioretinitis

Diagnostic algorithm

Host GroupTypical ManifestationDiagnosisFirst-line Therapy
ImmunocompetentAsymptomatic or mono-like adenopathyIgG/IgM serologyUsually none
Pregnant (primary)Maternal mild, fetal riskIgG avidity + amniotic PCRSpiramycin; pyrimethamine-sulfa if fetal infection
CongenitalChorioretinitis, hydrocephalus, calcificationsNeonatal IgM/IgA, PCRPyrimethamine + sulfadiazine + leucovorin x 1 yr
AIDS (CD4 <100)Ring-enhancing CNS lesionsMRI + empiric trialPyrimethamine + sulfadiazine + leucovorin
OcularChorioretinitis, floatersFunduscopy ± aqueous PCRPyrimethamine + sulfadiazine ± steroids
Toxoplasmosis: clinical presentation and treatment by host group.

Treatment

First-line

  • Acute acquired in immunocompetent host: typically no treatment unless severe or visceral disease
  • Ocular toxoplasmosis: pyrimethamine + sulfadiazine + leucovorin × 4-6 weeks; corticosteroids if vision-threatening
  • CNS toxoplasmosis (HIV/immunocompromised):
  • • Pyrimethamine 200 mg load then 50-75 mg PO daily + sulfadiazine 1-1.5 g PO QID + leucovorin 10-25 mg daily × 6 weeks induction
  • • Then chronic suppression at half doses until CD4 >200 × ≥6 months on ART
  • Alternative: TMP-SMX (effective and more accessible)
  • Pregnancy with primary infection: spiramycin to prevent fetal transmission; if fetal infection confirmed (amniotic fluid PCR), switch to pyrimethamine + sulfadiazine + leucovorin after 14 weeks gestation (avoid pyrimethamine in first trimester due to teratogenicity)
  • Congenital toxoplasmosis: pyrimethamine + sulfadiazine + leucovorin × 1 year

Second-line / adjunct

  • Clindamycin + pyrimethamine + leucovorin — sulfa allergy
  • Atovaquone + pyrimethamine + leucovorin — alternative
  • TMP-SMX as primary prophylaxis (CD4 <100 + positive toxo IgG) — covers both PCP and toxoplasmosis

Complications

  • Vision loss from chorioretinitis (recurrence common)
  • Cerebral abscess with mass effect, herniation
  • Cognitive impairment, seizures from CNS disease
  • Congenital: developmental delay, hearing loss, blindness, recurrent chorioretinitis
  • Toxoplasma encephalitis IRIS after starting ART

PANCE pearls

  • Pregnancy prevention: avoid undercooked meat, change litter daily and wear gloves, wash produce, drink filtered water.
  • Toxoplasma IgM can persist >1 year — do not interpret a positive IgM as recent infection without IgG avidity testing.
  • In HIV with CD4 <100 + positive toxoplasma IgG, TMP-SMX prophylaxis prevents both PCP and toxoplasmosis.
  • Empiric anti-toxo therapy in HIV with ring-enhancing lesions — clinical/radiographic response within 2 weeks supports the diagnosis; failure → biopsy to evaluate for lymphoma.
  • Congenital intracranial calcifications: toxoplasmosis is diffuse; CMV is periventricular.

References

  • DHHS OI — Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV — Toxoplasmosis section
  • CDC — Toxoplasmosis: Information for Healthcare Providers
  • Maldonado 2017 — AAP Diagnosis, Treatment, and Prevention of Congenital Toxoplasmosis in the United States (Pediatrics)

Practice Infectious Disease questions on FirstPassPA

Turn this outline into retention. 6,500+ board-style questions with an AI tutor that explains every answer — free to start, no card required.

Answer the 2 free questions above → Get today's free question →

Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA or PAEA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants; End of Rotation™ is a program of the Physician Assistant Education Association.